How Big Pharma Pursues ‘Killer Profits’ at Americans’ Expense

“Instead of spending on innovation, Big Pharma is hoarding its money for salaries and dividends,” the report says, “all while swallowing smaller companies, thus making the marketplace far less competitive.”